Abstract
The intrinsic dynamics of macromolecules is an essential property to relate the structure of biomolecular systems with their function in the cell. In the field of ligand-receptor recognition, numerous evidences have revealed the limitations of the lock-and-key theory, and the need to elaborate models that take into account the inherent plasticity of biomolecules, such as the induced-fit model or the existence of an ensemble of pre-equilibrated conformations. Depending on the nature of the target system, ligand binding can be associated with small local adjustments in side chains or even the backbone to large-scale motions of structural fragments, domains or even subunits. Reproducing the inherent flexibility of biomolecules has thus become one of the most challenging issues in molecular modeling and simulation studies, as it has direct implications in our understanding of the structure-function relationships, but even in areas such as virtual screening and structure-based drug discovery. Given the intrinsic limitation of conventional simulation tools, only events occurring in short time scales can be reproduced at a high accuracy level through all-atom techniques such as Molecular Dynamics simulations. However, larger structural rearrangements demand the use of enhanced sampling methods relying on modified descriptions of the biomolecular system or the potential surface. This review illustrates the crucial role that structural plasticity plays in mediating ligand recognition through representative examples. In addition, it discusses some of the most powerful computational tools developed to characterize the conformational flexibility in ligand-receptor complexes.
Keywords: Molecular recognition, conformational flexibility, ligand-receptor complex, induced-fit, molecular dynamics, drug design, Protein, Ligand, Molecular Modeling, subunits, flexibility, biomolecules, computational tools, ligand-receptor complexes, antibodies, DNA, Gibbs's free energy, hydrophobic, tautomerization, NMR, pH, temperature, apo forms, LMW-PTP, Torpedo californica, enzyme, Trp84, AChE, Phe330, huprine X, edrophonium, piperidine, decamethonium, donepezil, 1 Å, Renin, kinases, phos-phorylation, AL. DFG-out, ATP, RNA helicase, CBF, Calmodulin, Glutamate Dehydrogenase, Replica Exchange, HIV-1 protease, FEP, FDTI
Current Topics in Medicinal Chemistry
Title: Protein Flexibility and Ligand Recognition: Challenges for Molecular Modeling
Volume: 11 Issue: 2
Author(s): Francesca Spyrakis, Axel BidonChanal, Xavier Barril and F. Javier Luque
Affiliation:
Keywords: Molecular recognition, conformational flexibility, ligand-receptor complex, induced-fit, molecular dynamics, drug design, Protein, Ligand, Molecular Modeling, subunits, flexibility, biomolecules, computational tools, ligand-receptor complexes, antibodies, DNA, Gibbs's free energy, hydrophobic, tautomerization, NMR, pH, temperature, apo forms, LMW-PTP, Torpedo californica, enzyme, Trp84, AChE, Phe330, huprine X, edrophonium, piperidine, decamethonium, donepezil, 1 Å, Renin, kinases, phos-phorylation, AL. DFG-out, ATP, RNA helicase, CBF, Calmodulin, Glutamate Dehydrogenase, Replica Exchange, HIV-1 protease, FEP, FDTI
Abstract: The intrinsic dynamics of macromolecules is an essential property to relate the structure of biomolecular systems with their function in the cell. In the field of ligand-receptor recognition, numerous evidences have revealed the limitations of the lock-and-key theory, and the need to elaborate models that take into account the inherent plasticity of biomolecules, such as the induced-fit model or the existence of an ensemble of pre-equilibrated conformations. Depending on the nature of the target system, ligand binding can be associated with small local adjustments in side chains or even the backbone to large-scale motions of structural fragments, domains or even subunits. Reproducing the inherent flexibility of biomolecules has thus become one of the most challenging issues in molecular modeling and simulation studies, as it has direct implications in our understanding of the structure-function relationships, but even in areas such as virtual screening and structure-based drug discovery. Given the intrinsic limitation of conventional simulation tools, only events occurring in short time scales can be reproduced at a high accuracy level through all-atom techniques such as Molecular Dynamics simulations. However, larger structural rearrangements demand the use of enhanced sampling methods relying on modified descriptions of the biomolecular system or the potential surface. This review illustrates the crucial role that structural plasticity plays in mediating ligand recognition through representative examples. In addition, it discusses some of the most powerful computational tools developed to characterize the conformational flexibility in ligand-receptor complexes.
Export Options
About this article
Cite this article as:
Spyrakis Francesca, BidonChanal Axel, Barril Xavier and Javier Luque F., Protein Flexibility and Ligand Recognition: Challenges for Molecular Modeling, Current Topics in Medicinal Chemistry 2011; 11 (2) . https://dx.doi.org/10.2174/156802611794863571
DOI https://dx.doi.org/10.2174/156802611794863571 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Challenges, Consequences and Possible Treatments of Anticancer Drug Discovery ll
The use of several compounds has been the subject of increasing interest in phytochemistry, biochemistry, and other fields of research at the chemistry-biology-ecosystems interface. In spite of the continued search for new anticancer drugs, cancer remains a leading cause of death. Cancer mortalities are expected to increase to 12.9 million, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
FK506-Binding Proteins and Their Diverse Functions
Current Molecular Pharmacology Healthspan and Longevity in Mammals: A Family Game for Cellular Organelles?
Current Pharmaceutical Design The Endocannabinoid System and Huntingtons Disease
Current Drug Targets - CNS & Neurological Disorders Atypical GTPases as Drug Targets
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Management of Huntingtons Disease: An Evidence- Based Review
Current Pharmaceutical Design Screening and Identification of Differentially Expressed Genes Between Diabetic Nephropathy Glomerular and Normal Glomerular via Bioinformatics Technology
Combinatorial Chemistry & High Throughput Screening Ghrelin as a Neuroprotective and Palliative Agent in Alzheimer's and Parkinson's Disease
Current Pharmaceutical Design Global View on Rare Diseases: A Mini Review
Current Medicinal Chemistry Surgical Outcome of Peripheral Nerve Injury
New Emirates Medical Journal Apoptosis Induction by Ultrasound and Microbubble Mediated Drug Delivery and Gene Therapy
Current Molecular Medicine Herbal Medicine for Anxiety, Depression and Insomnia
Current Neuropharmacology The GABAA-BZR Complex as Target for the Development of Anxiolytic Drugs
Current Topics in Medicinal Chemistry Ongoing Electroencephalographic Activity Associated with Cortical Arousal in Transgenic PDAPP Mice (hAPP V717F)
Current Alzheimer Research Diabetic Gastroenteropathy: Soothe the Symptoms or Unravel a Cure?
Current Diabetes Reviews Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Losartan: A Pharmacotherapy in Cardiovascular Disease
New Emirates Medical Journal Structural Characterization, Homology Modeling and Docking Studies of ARG674 Mutation in MyH8 Gene Associated with Trismus-Pseudocamptodactyly Syndrome
Letters in Drug Design & Discovery Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeo - static Signaling
Current Psychopharmacology Disorders of Primary Metabolites in Response to Drought May Increase the Synthesis of Natural Products for Medicinal Purposes: South American Herbs - a Case Study
Recent Patents on Biotechnology Can Probiotics Cure Inflammatory Bowel Diseases?
Current Pharmaceutical Design